| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$27,618,890 |
|
|
|
Indirect Value
|
$97,197,843 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$124,816,733 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
• • • |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,552,241 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
86,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
163,304 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • • |
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
624,240 |
624,240 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
635,640 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,121 |
557,519 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,700 |
527,147 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-12-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
27,500 |
419,647 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
432,647 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
450,069 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2018-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,429 |
452,384 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
470,472 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
20,000 |
470,473 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,435 |
470,220 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,435 |
475,914 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,782 |
511,696 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
33,453 |
612,394 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
52,041 |
634,226 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
54,916 |
615,606 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
41,560 |
563,913 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-10-31 |
4 |
AB |
$13.35 |
$4,233 |
D/D |
317 |
115,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$6,754 |
D/D |
1,924 |
25,034 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2005-05-02 |
4 |
A |
$3.43 |
$6,758 |
D/D |
1,968 |
27,002 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• – – |
2005-10-31 |
4 |
A |
$3.43 |
$8,832 |
D/D |
2,572 |
29,574 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-10-31 |
4 |
B |
$6.92 |
$14,101 |
D/D |
2,038 |
96,164 |
2.74 |
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
